Search
Displaying 311–320 of 1066 results
-
Retinal Research Community Loses Beloved Pioneer Sam Jacobson
Beacon StoriesHis many contributions included pivotal work that led to LUXTURNA
-
Fearless Sister Duo Finding Hope
Beacon StoriesApril LuFriu and Melissa Escobio are sisters and best friends who do just about everything together, including having retinitis pigmentosa (RP).
-
Eye on the Cure Podcast | Episode 38: Ben Shaberman
Eye on the CureJanuary 6, 2023. For the first Eye on the Cure episode for 2023, host Ben Shaberman highlights some of the promising clinical advancement made in therapy development over the last year.
-
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
In the PressThe investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
A variety of resources for your endurance fundraising activities.
-
Eye on the Cure Podcast | Episode 37: Rando Allikmets, PhD
Eye on the CureDecember 16, 2022. Rando Allikmets, PhD, talks to host Ben Shaberman.
-
Resourceful Advocate for Research
Beacon StoriesManorthia was diagnosed with retinitis pigmentosa (RP) when she was 22 years old but didn’t start experiencing considerable vision loss until years later. Once she began to notice her vision deteriorating more rapidly, she reached out to the Foundation Fighting Blindness to get involved with the blindness community.
-
Hello my name is Josephine Ortega , I am a college student continuing her passion of art despite me being visually impaired. I was diagnosed with Stargardt disease when I was a child. A rare genetic eye disease that loses the central vision overtime as a child to adulthood.
-
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
Research NewsThe emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
.png)
.png)
.png)
